StockNews.com Begins Coverage on NeuroMetrix (NASDAQ:NURO)

StockNews.com started coverage on shares of NeuroMetrix (NASDAQ:NURO) in a report released on Tuesday. The brokerage issued a sell rating on the medical device company’s stock.

NeuroMetrix Stock Down 0.2 %

Shares of NURO stock opened at $3.70 on Tuesday. The company’s fifty day simple moving average is $3.75 and its 200-day simple moving average is $3.74. The firm has a market cap of $7.44 million, a PE ratio of -0.59 and a beta of 2.30. NeuroMetrix has a 12 month low of $2.70 and a 12 month high of $7.84.

NeuroMetrix (NASDAQ:NURO) last announced its quarterly earnings data on Wednesday, May 15th. The medical device company reported ($1.67) EPS for the quarter. The business had revenue of $1.09 million during the quarter. NeuroMetrix had a negative return on equity of 39.85% and a negative net margin of 151.51%.

Institutional Trading of NeuroMetrix

An institutional investor recently bought a new position in NeuroMetrix stock. Cerity Partners LLC purchased a new position in shares of NeuroMetrix, Inc. (NASDAQ:NURO) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 30,000 shares of the medical device company’s stock, valued at approximately $108,000. Cerity Partners LLC owned approximately 2.80% of NeuroMetrix at the end of the most recent quarter. Hedge funds and other institutional investors own 19.40% of the company’s stock.

NeuroMetrix Company Profile

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.